在人类尿液中对酸盐火山化加速剂的暴露评估
Lin Gao1, Yetian Liang1, Qinle Wang1
1Taizhou Central Hospital (Taizhou University Hospital), School of Medicine, Taizhou University, Taizhou, Zhejiang 318000, PR China.
Ecotoxicology and environmental safety
|July 1, 2025
概括
人类尿液中存在酸硫化加速剂 (XVA),酸丁和酸氨基含量最高. 这项研究提供了关于人类对这些化合物的暴露的关键数据.
科学领域:
- 环境化学环境化学
- 毒理学 毒理学 毒理学
- 人类暴露评估评估
背景情况:
- 酸盐火山化加速器 (XVA) 在尘埃中被广泛检测到,这表明人类潜在的暴露风险.
- 人体尿液中XVAs的全面研究缺乏,这是暴露的关键生物标志物.
研究的目的:
- 系统地调查中国泰州市健康成年人尿液中8种XVA同类物质的存在和度.
- 建立XVA对人类暴露的基本数据,以协助健康风险评估.
主要方法:
- 在城市泰州市,从218名健康成年人收集了尿液样本.
- 使用系统检查方法分析了八种XVA同类物质.
- 确定XVAs的尿度和每日暴露 (DE) 量化.
主要成果:
- 所有向的XVA化合物都在人体尿样中检测到.
- 丁酸盐 (KBX) 和胺酸盐 (KAX) 显示出尿液中最高的平均水平.
- 与女性相比,男性的尿液中KAX,乙烯酸盐 (KPX) 和乙烯酸盐 (KEX) 的平均度较高.
- 观察到KAX,KBX和KEX的尿度与年龄相关的下降.
- 最高的平均每日暴露量记录在KBX (906 ng/kg bw/day) 和KAX (718 ng/kg bw/day) 上.
结论:
- 这项研究提供了人类尿液中XVAs的首次全面分析.
- 该研究建立了关于人类暴露于XVAs的基本基线数据.
- 这些发现对于评估XVA暴露对健康的潜在影响至关重要.
更多相关视频
08:41Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
Published on: July 14, 2017
9.4K
10:10Assessment of the Acute Inhalation Toxicity of Airborne Particles by Exposing Cultivated Human Lung Cells at the Air-Liquid Interface
Published on: February 23, 2020
7.1K
相关概念视频
Urine Studies I: Urinalysis
166
Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
166
One-Compartment Open Model: Urinary Excretion Data and Determination of k
293
The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also...
293
